| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/09/2000 | CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone |
| 08/09/2000 | CN1262272A HIV proteinase inhibitor |
| 08/09/2000 | CN1262269A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 08/08/2000 | US6100404 Erythromycin compounds |
| 08/08/2000 | US6100284 Antiallergens |
| 08/08/2000 | US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts |
| 08/03/2000 | WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors |
| 08/03/2000 | WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents |
| 08/03/2000 | WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | WO2000006146A9 Substituted anilide compounds and methods |
| 08/03/2000 | DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis |
| 08/03/2000 | CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors |
| 08/02/2000 | EP1024134A1 Aminobutanoic acid derivatives |
| 08/02/2000 | EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 08/02/2000 | CN1261883A Novel compounds |
| 08/01/2000 | US6096794 Photoinitiator system for photopolymerization of ethylenically unsaturated polymerizable compounds |
| 08/01/2000 | US6096782 Administering an alanine containing peptide to the alzhiemer's patient |
| 08/01/2000 | US6096735 Benzoheterocyclic derivatives |
| 08/01/2000 | US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents |
| 08/01/2000 | CA2019335C Phenylalkan (en)oic acids |
| 07/27/2000 | WO2000043366A1 Quinoline derivatives and quinazoline derivatives |
| 07/27/2000 | WO2000043008A1 Anti-androgens and methods for treating disease |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | WO2000012500A3 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 07/26/2000 | EP1021425A1 N-aminoalkyl-2-anthraquinonecarboxamides; dopamine receptor subtype specific ligands |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/26/2000 | CN1261356A Substituted aminobeterocyclylamides |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261284A Use of a CD40 : CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 07/26/2000 | CN1054845C Quinoline compounds, their preparing methods and medicinal compositions |
| 07/25/2000 | US6093821 Process for preparing steroid receptor modulator compounds |
| 07/25/2000 | US6093742 Inhibitors of p38 |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093729 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
| 07/20/2000 | WO2000042026A1 Non-peptide glp-1 agonists |
| 07/20/2000 | WO2000042016A1 Process for producing quinolinecarbaldehyde |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/19/2000 | EP1020468A2 Methods and intermediates for the asymmetric synthesis of camptothecin and camptothecin analogs |
| 07/19/2000 | EP1019377A1 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (nk-3)- and neurokinin 2 (nk-2) receptor antagonists. |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof |
| 07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
| 07/18/2000 | US6090865 Polymerizable composition |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090821 Substituted quinolin-2 (1H)-ones useful as HIV reverse transcriptase inhibitors |
| 07/18/2000 | US6090810 Side effect reduction |
| 07/18/2000 | CA2017376C Diarylstyrylquinoline diacids |
| 07/13/2000 | WO2000040563A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040562A1 2-oxoquinoline compounds and medicinal uses thereof |
| 07/13/2000 | WO2000040561A1 Quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
| 07/13/2000 | CA2358879A1 2-oxoquinoline compounds and pharmaceutical uses thereof |
| 07/13/2000 | CA2353636A1 Quinolinecarboxamides as antiviral agents |
| 07/13/2000 | CA2353634A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/12/2000 | EP1018513A2 Quinolinecarboxylic acid derivatives |
| 07/12/2000 | EP1017692A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 07/12/2000 | EP1017691A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 07/12/2000 | EP1017677A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
| 07/12/2000 | EP1017676A1 Method for the synthesis of quinoline derivatives |
| 07/12/2000 | EP1017664A1 C3a receptor ligands |
| 07/12/2000 | EP0877734B1 Quinoline and quinazoline compounds useful in therapy |
| 07/12/2000 | CN1259516A Method for purifying industrial quinoline to produce fine products |
| 07/11/2000 | US6087503 Quinoline derivatives, their production and use |
| 07/11/2000 | US6087399 Sulfonamide-substituted compounds, process for their preparation, their use as a medicament or diagnostic, and a medicament comprising them |
| 07/11/2000 | US6087365 Treating drug-resistant malaria in a mammal |
| 07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
| 07/06/2000 | WO2000039082A2 1,2-annelated quinoline derivatives |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038685A1 Solution phase synthesis of compounds including amine alcohol functionality |
| 07/06/2000 | WO2000038682A1 Anti-hiv infection agents and method for treating hiv infection |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2356453A1 Anti-hiv infection agents and method for treating hiv infection |
| 07/05/2000 | EP1015445A1 Antimicrobial quinolones, their compositions and uses |
| 07/05/2000 | EP0565621B1 Method of making camptothecin and camptothecin analogs |
| 07/05/2000 | CN1259125A Substituted 3-cyano quinolines |
| 07/05/2000 | CN1259124A 4-quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient |
| 07/05/2000 | CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component |
| 07/05/2000 | CN1258672A Amino-compound |
| 07/05/2000 | CN1054124C Aminoquinoline derivatives and its application of salt |
| 07/04/2000 | US6084120 β-Alkoxyacrylates against malaria |
| 07/04/2000 | US6083959 Quinoline derivatives, processes for their preparation and their use as medicaments |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000036921A1 Fungicide mixture |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/28/2000 | EP1012892A1 Electroluminescent device |